|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Modified drug releases dosage form based on cardiovascular system |
| Authors Name: | Miss. Priyanka Sanjay Sonawane , Dr. Amol Gayke |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_201403
|
| Published Paper Id: | IJNRD2307221 |
| Published In: | Volume 8 Issue 7, July-2023 |
| DOI: | |
| Abstract: | A range of disease states, including atherosclerosis, ischemic-reperfusion injury, and various types of microvascular disorders, including hypertension, may be successfully treated via therapeutic administration to the cardiovascular system. Adenosin A2A receptor agonist (CGS 21680), CYPepoxygenases inhibitor (N-(methylsulfonyl)-2-(2-propynyloxy)-benzenehexanamide), trans-4-[4(3-adamantan-1-ylureido)cyclohexyloxy] benzoic acid, soluble epoxide hydrolase inhibitor (Nmethylsulfonyl Effective nanoproduct formulations have the potential to significantly improve patient treatment results by overcoming physiological obstacles. According to the research on targeted distribution to the cardiovascular system, we discovered that this field is still developing.compared to the more developed disciplines of tumour cancer or brain delivery, which have fewer publications focusing on the targeted drug delivery methods, are still in their infancy. We also demonstrate the importance of a thorough understanding of pharmacology in relation to the cardiovascular system. As a result, we covered numerous receptor agonists, antagonists, activators, and inhibitors in this review that would have an impact on the cardiovascular system. |
| Keywords: | |
| Cite Article: | "Modified drug releases dosage form based on cardiovascular system", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 7, page no.c215-c220, July-2023, Available :http://www.ijnrd.org/papers/IJNRD2307221.pdf |
| Downloads: | 000118759 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2307221 Registration ID: 201403 Published In: Volume 8 Issue 7, July-2023 DOI (Digital Object Identifier): Page No: c215-c220 Country: Sambhajinagar , Maharashtra , India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2307221 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2307221 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn